Cargando…
Recent Advances in Allogeneic CAR-T Cells
In recent decades, great advances have been made in the field of tumor treatment. Especially, cell-based therapy targeting tumor associated antigen (TAA) has developed tremendously. T cells were engineered to have the ability to attack tumor cells by generating CAR constructs consisting of genes enc...
Autores principales: | Kim, Dong Wook, Cho, Je-Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072190/ https://www.ncbi.nlm.nih.gov/pubmed/32050611 http://dx.doi.org/10.3390/biom10020263 |
Ejemplares similares
-
Recent advances in CAR-T cell engineering
por: Huang, Ruihao, et al.
Publicado: (2020) -
Recent advances in CAR T-cell therapy for lymphoma in China
por: Che, Yuxuan, et al.
Publicado: (2023) -
Allogeneic CAR-T Cells: More than Ease of Access?
por: Graham, Charlotte, et al.
Publicado: (2018) -
Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023) -
Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia
por: Lee, Sung-Eun, et al.
Publicado: (2018)